TLRY

Tilray Brands delivered strong Q4 revenue growth, driven by the BrewDog acquisition, but shares hit new lows due to ongoing dilution. Despite revenue gains, most segment gross margins stagnated, and adjusted net income fell 60% year over year, highlighting persistent profitability challenges. The company's valuation remains quite depressed compared to peer Canopy Growth, which is expected to show more revenue growth.

Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.2 per share a year ago.

Record Fiscal Year Net Revenue of $ 915 Million, Record Gross Profit, Consistent Adjusted Gross Margin3 and Record Adjusted EBITDA5 Highlights the Strength of Tilray's Scaled Businesses and Profitable Growth Strategy International Medical Cannabis Revenue Increased 34% for the Fiscal Year, Reinforcing Tilray's Leadership Across Europe and Expanding Patient Access at Scale BrewDog Acquisition Ignited the Global Expansion of Tilray's Beverage Platform, Unlocking New Growth Through the Power of Brands, Hospitality and Consumer Experiences Disciplined Capital Allocation Strengthens Balance Sheet with Approximately  $235 Million in Cash, Restricted Cash and Marketable Securities1; Net Debt2 Reduced to $0.7 Million Fiscal Year 2027 Guidance of Adjusted EBITDA5 of $68 Million to $75 Million, Reflecting Double-Digit Growth Driven by Continued Momentum NEW YORK and LONDON and LEAMINGTON, Ontario, July 28, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, hospitality and wellness industries, today reported financial results for its fourth quarter and fiscal year ended May 31, 2026. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

New spirits line brings the bold blood orange and honey profile of Revolver's iconic Blood & Honey beer to Whiskey, Gin and Vodka launching exclusively in Texas New spirits line brings the bold blood orange and honey profile of Revolver's iconic Blood & Honey beer to Whiskey, Gin and Vodka launching exclusively in Texas

TORONTO, July 23, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, wellness, and beverage industries, today announced the launch of ZONNA, a new cannabis brand introducing fast-acting THC pouches designed for adult consumers seeking a discreet, smoke-free, and convenient cannabis experience. Launching with Bubble Pink, ZONNA combines innovative Capsoil™ technology with a portable pouch design to deliver a fast-acting experience.

The cannabis industry continues evolving despite ongoing regulatory uncertainty across North America. Investors remain focused on companies with improving financial results and stronger balance sheets. At the same time, the potential for federal reform in the United States continues supporting long-term optimism. Many operators are also reducing costs while expanding higher-margin businesses. As a result, investors are paying closer attention to companies with disciplined management teams. Canadian cannabis producers also continue increasing their international footprints. Furthermore, several companies are generating meaningful revenue outside recreational cannabis. That diversification could help reduce risk during slower industry growth periods.

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.23, moving 1.63% from the previous trading session.

BrewDog and Tilray are keeping football's biggest celebration alive by unlocking the £1 million bar tab at participating pubs 1 beginning July 20 because great football deserves celebrating, no matter who lifts the trophy

For investors looking to make more green, marijuana stocks may be the way to go. Contrary to the doubt or fear based on the past, the cannabis industry is growing at a fast pace. Now, with cannabis classified as a Class 3 substance, there is very little barrier for legal operators. What that means is now there can be more product research and testing.